NewGenIvf Group (NIVF) Income Statement (2021 - 2025)
Income Statement report data from Mar 31, 2021 to Dec 31, 2025 for NewGenIvf Group (NIVF).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Dec 31, 2025 | Sep 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Sep 30, 2021 | Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | |||||||||||||||
Total Revenue | 1.42M (+10.94%) | 1.28M (+0.79%) | 1.27M (0.00%) | 1.27M (-13.61%) | 1.47M (-3.29%) | 1.52M | - | - | - | - | - | - | - | - | - |
Cost Of Revenue | 900K (-22.41%) | 1.16M (+58.90%) | 730K (0.00%) | 730K (-10.98%) | 820K (-37.88%) | 1.32M | - | - | - | - | - | - | - | - | - |
Costof Goods And Services Sold | 900K (-22.41%) | 1.16M (+58.90%) | 730K (0.00%) | 730K (-10.98%) | 820K (-37.88%) | 1.32M | - | - | - | - | - | - | - | - | - |
Gross Profit | 520K (+333.33%) | 120K (-77.78%) | 540K (0.00%) | 540K (-16.92%) | 650K (+225.00%) | 200K | - | - | - | - | - | - | - | - | - |
Operating Expenses | |||||||||||||||
Selling General And Administrative | 4.80M (+96.72%) | 2.44M (+51.55%) | 1.61M (-1.23%) | 1.63M (+443.33%) | 300K | - | - | - | - | - | - | - | - | - | - |
Operating Expenses | 5.50M (+109.13%) | 2.63M (+61.35%) | 1.63M (-30.93%) | 2.36M (+448.84%) | 430K (-66.14%) | 1.27M (0.00%) | 1.27M (+234.21%) | 380K (+2.70%) | 370K (-27.45%) | 510K (+325.00%) | 120K (+9.09%) | 110K (-8.33%) | 120K | - | - |
Depreciation And Amortization | - | - | 180K | - | 10K (-94.12%) | 170K | - | - | - | - | - | - | - | - | - |
Operating Income | |||||||||||||||
Operating Income | -4.97M (+98.01%) | -2.51M (+130.28%) | -1.09M (0.00%) | -1.09M | 220K | -1.27M (0.00%) | -1.27M (+234.21%) | -380.00K (+2.70%) | -370.00K (-27.45%) | -510.00K (+325.00%) | -120.00K (+9.09%) | -110.00K (-8.33%) | -120.00K | - | - |
Ebit | - | - | -120.00K | - | 220K (-21.43%) | 280K | -1.27M (+234.21%) | -380.00K (+2.70%) | -370.00K (-27.45%) | -510.00K (+325.00%) | -120.00K (+9.09%) | -110.00K (-8.33%) | -120.00K | - | - |
EBITDA | -7.27M | 17M (+27900.00%) | 60K | - | 230K (-48.89%) | 450K | -1.27M | 130K (+44.44%) | 90K (+80.00%) | 50K (-89.36%) | 470K (+123.81%) | 210K | -30.00K | - | - |
Other Income / Expenses | |||||||||||||||
Interest Income | - | - | - | - | 10K | - | - | - | - | - | - | - | - | - | - |
Interest Expense | 440K (+780.00%) | 50K (-88.10%) | 420K (0.00%) | 420K (+68.00%) | 250K (+733.33%) | 30K | - | - | - | - | - | - | - | - | - |
Net Interest Income | -440.00K (+780.00%) | -50.00K | - | -420.00K (+68.00%) | -250.00K | - | - | - | - | - | - | - | - | - | - |
Net Income | |||||||||||||||
Income Before Tax | -7.72M | 17M | -540.00K (0.00%) | -540.00K (+1700.00%) | -30.00K (-96.84%) | -950.00K (-1.04%) | -960.00K | 130K (+44.44%) | 90K (+80.00%) | 50K (-89.36%) | 470K (+123.81%) | 210K | -30.00K | - | - |
Income Tax Expense | - | - | -490.00K | - | - | -950.00K | - | - | - | - | - | - | - | - | - |
Net Income From Continuing Operations | -7.72M | 17M | - | -60.00K (+100.00%) | -30.00K | - | - | - | - | - | - | - | - | - | - |
Net Income | -7.67M | 17M | -110.00K (0.00%) | -110.00K (+450.00%) | -20.00K (-97.89%) | -950.00K (-1.04%) | -960.00K | 130K (+44.44%) | 90K (+80.00%) | 50K (-89.36%) | 470K (+123.81%) | 210K | -30.00K | - | - |